|
FAM107B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99051886085044E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.1774582964772E-12 |
| Normal-vs-Stage2 |
3.43410000436251E-09 |
| Normal-vs-Stage3 |
1.38289999995767E-06 |
| Normal-vs-Stage4 |
1.98752999999163E-05 |
| Stage1-vs-Stage2 |
9.274600E-01 |
| Stage1-vs-Stage3 |
5.964800E-01 |
| Stage1-vs-Stage4 |
9.242600E-01 |
| Stage2-vs-Stage3 |
6.426200E-01 |
| Stage2-vs-Stage4 |
9.775400E-01 |
| Stage3-vs-Stage4 |
7.272800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.67799149312032E-13 |
| Normal-vs-AfricanAmerican |
5.93419979821874E-10 |
| Normal-vs-Asian |
4.022000E-01 |
| Caucasian-vs-AfricanAmerican |
6.027400E-01 |
| Caucasian-vs-Asian |
3.292200E-01 |
| AfricanAmerican-vs-Asian |
1.801590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
3.09080000038264E-07 |
| Male-vs-Female |
1.733190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.62649926649783E-12 |
| Normal-vs-Extreme_Weight |
1.62536650805123E-12 |
| Normal-vs-Obese |
2.88059998077017E-09 |
| Normal-vs-Extreme_Obese |
1.56046999999493E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.294400E-01 |
| Normal_Weight-vs-Obese |
9.573500E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.463600E-01 |
| Extreme_Weight-vs-Obese |
1.115400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.678400E-01 |
| Obese-vs-Extreme_Obese |
6.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.70139999997343E-06 |
| Normal-vs-Age(41-60Yrs) |
4.50290027487199E-10 |
| Normal-vs-Age(61-80Yrs) |
1.01585406753202E-13 |
| Normal-vs-Age(81-100Yrs) |
1.01880004432786E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.354200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.699000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.795350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.297900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.000040E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.499800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.26074714504421E-12 |
| Normal-VS-Type2 PRCC |
6.79456491070596E-14 |
| Normal-VS-KIRP CIMP |
3.100300E-02 |
| Normal-VS-Unclassified PRCC |
1.919730E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.694600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.772600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.185000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.704300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.238620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.508400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.2110000497122E-09 |
| Normal-vs-N1 |
3.256199999635E-07 |
| Normal-vs-N2 |
3.212400E-01 |
| N0-vs-N1 |
6.569600E-01 |
| N0-vs-N2 |
5.521200E-01 |
| N1-vs-N2 |
6.621600E-01 |
|
|
